시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 여행자 설사 치료 시장 보고서(2025년)
Traveler´s Diarrhea Treatment Global Market Report 2025
상품코드 : 1720912
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,586,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,520,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,454,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

여행자 설사 치료 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 예측 기간 동안 예상되는 성장은 식중독 사례의 증가, 셀리악병 진단 건수의 증가, 설사 방지제에 대한 수요 증가, 모험과 생태 관광의 인기 증가, 그리고 해외 여행 증가에 기인한다고 생각됩니다. 이 기간의 주요 동향으로는 신규 치료법의 개발, 프로바이오틱스나 마이크로바이옴 기반의 치료법의 사용, 신속 진단 툴의 진보, 예방 백신의 도입, 위장약의 지속적인 성장 등을 들 수 있습니다.

여행자 증가가 여행자 설사 치료 시장의 확대를 견인할 것으로 예측됩니다. 여행객 증가에 기여하는 요인으로는 가처분 소득 증가, 저가 항공사의 성장, 비자 요건 간소화, 체험 관광의 인기 상승 등이 있습니다. 여행자 설사 치료는 증상을 빠르게 완화하고 탈수를 방지하며 빠른 회복을 가능하게 하여 여행자가 최소한의 방해로 여행을 계속할 수 있도록 도와줍니다. 2023년 3월 미국 교통통계국은 미국 항공사들이 2022년에 8억 5,300만 명의 승객을 수송했으며, 이는 2021년의 6억 5,800만 명에서 1억 9,400만 명 증가한 수치라고 보고했습니다. 그 결과 여행의 급증이 여행자 설사 치료 시장의 성장을 견인하고 있습니다.

식중독 환자 수 증가는 여행자 설사 치료 시장의 성장을 가속할 것으로 예측됩니다. 중독 환자 증가는 부적절한 식품 취급, 살모넬라 및 대장균과 같은 박테리아 오염, 불충분한 냉장, 가공 식품 및 조리 식품의 소비량 증가와 같은 요인과 관련이 있습니다. 치료는 수분 보급 요법, 항균제, 프로바이오틱스를 통해 탈수, 메스꺼움, 복부 경련 등의 식중독 증상을 관리하고 조기 회복과 합병증의 경감을 촉진합니다. EU는 2022년에 5,763건의 식중독이 발생했으며, 2021년에 비해 44% 증가했다고 보고했습니다. 그 결과, 식중독의 발생률 증가가 여행자 설사 치료 시장의 성장에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Traveler's diarrhea is a common illness that occurs when individuals consume contaminated food or water while traveling. It is typically marked by frequent, loose stools, abdominal cramps, and sometimes nausea or vomiting. Treatment focuses on rehydration with oral rehydration solutions, the use of anti-diarrheal medications such as loperamide, and antibiotics in more severe cases.

The primary types of drugs used to treat traveler's diarrhea include antibiotics, anti-diarrheal medications, and other drug types. Antibiotics work by treating bacterial infections, either killing bacteria or inhibiting their growth. These drugs are administered through various routes, including oral and parenteral, and are used in treating both adult and children's traveler's diarrhea. The main end users of these medications include hospitals, homecare settings, specialty clinics, and other healthcare providers.

The traveler's diarrhea treatment market research report is one of a series of new reports from The Business Research Company that provides traveler's diarrhea treatment market statistics, including the traveler's diarrhea treatment industry global market size, regional shares, competitors with the traveler's diarrhea treatment market share, detailed traveler's diarrhea treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the traveler's diarrhea treatment industry. This traveler's diarrhea treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The traveler's diarrhea treatment market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.60 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing cases of viral, bacterial, and parasitic infections, a rise in chronic diseases, greater awareness of travel-related illnesses, a higher prevalence of traveler's diarrhea, and an increase in food poisoning incidents.

The traveler's diarrhea treatment market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period can be attributed to the rising prevalence of food poisoning cases, an increasing number of celiac disease diagnoses, a higher demand for anti-diarrheal medications, the growing popularity of adventure and eco-tourism, and a rise in international travel. Key trends during this period include the development of novel treatments, the use of probiotics and microbiome-based therapies, advancements in rapid diagnostic tools, the introduction of vaccines for prevention, and the continued growth of gastrointestinal drugs.

The growing number of travelers is expected to drive the expansion of the traveler's diarrhea treatment market. Travelers are individuals who move from one location to another, typically for leisure, business, or other reasons. Factors contributing to the rise in travelers include increasing disposable incomes, the growth of budget airlines, simplified visa requirements, and the rising popularity of experiential tourism. Traveler's diarrhea treatments assist by quickly alleviating symptoms, preventing dehydration, and enabling faster recovery, allowing travelers to continue their trips with minimal disruption. For example, in March 2023, the Bureau of Transportation Statistics reported that U.S. airlines transported 853 million passengers in 2022, an increase of 194 million from the 658 million carried in 2021. Consequently, the surge in travel is driving the growth of the traveler's diarrhea treatment market.

The increasing number of food poisoning cases is also expected to fuel the growth of the traveler's diarrhea treatment market. Food poisoning occurs from consuming contaminated food or beverages, often due to bacteria, viruses, parasites, or toxins. The rise in food poisoning cases is linked to factors such as improper food handling, contamination by bacteria such as Salmonella and E. coli, inadequate refrigeration, and a higher consumption of processed and ready-to-eat foods. Treatments for traveler's diarrhea help manage food poisoning symptoms such as dehydration, nausea, and abdominal cramps through rehydration therapy, antimicrobial medications, and probiotics, promoting quicker recovery and reducing complications. In December 2024, the European Food Safety Authority reported that the EU saw 5,763 foodborne outbreaks in 2022, reflecting a 44% increase compared to 2021. As a result, the growing incidence of food poisoning is contributing to the growth of the traveler's diarrhea treatment market.

Companies in the traveler's diarrhea treatment market are also focusing on developing innovative products such as delayed-release tablets to enhance treatment efficacy and reduce dosing frequency. These tablets are designed to release active ingredients at specific times after ingestion, ensuring the medication reaches the intestines before dissolving, which helps treat traveler's diarrhea effectively while minimizing stomach irritation. For example, in September 2023, Adalvo Ltd., based in Malta, partnered with Cosmo Pharmaceuticals N.V., based in Ireland, to launch Rifamycin SV MMX 200 mg (Aemcolo). This medication treats traveler's diarrhea by delivering a non-absorbed antibiotic directly to the colon, alleviating symptoms while minimizing disruption to beneficial gut bacteria. This targeted approach offers effective relief with a lower risk of systemic side effects and multi-drug resistance.

Major players in the traveler's diarrhea treatment market are Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., C.H. Boehringer Sohn AG & Co. KG, Astellas Pharma Inc., Aurobindo Pharma Limited, Lupin Pharmaceuticals Inc., Mallinckrodt plc, Glenmark Pharmaceuticals Ltd., Indivior plc, Immuron Limited, Valneva SE, Cosmo Pharmaceuticals N.V., Otsuka Pharmaceutical Co. Ltd., Lumen Bioscience Inc., RedHill Biopharma Ltd., Brown & Burk Pharmaceuticals Ltd., Scandinavian Biopharma Holding AB.

North America was the largest region in the traveler's diarrhea treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in traveler's diarrhea treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the traveler's diarrhea treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The traveler's diarrhea treatment market consists of revenues earned by entities by providing services such as probiotics and preventive supplements, telemedicine and online consultations, travel vaccinations and preventive care, medical insurance and assistance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The traveler's diarrhea treatment market also includes sales of oral rehydration salts (ORS), antimotility agents, probiotics, and bismuth subsalicylate products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Traveler's Diarrhea Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on traveler's diarrhea treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for traveler's diarrhea treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The traveler's diarrhea treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Traveler's Diarrhea Treatment Market Characteristics

3. Traveler's Diarrhea Treatment Market Trends And Strategies

4. Traveler's Diarrhea Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Traveler's Diarrhea Treatment Growth Analysis And Strategic Analysis Framework

6. Traveler's Diarrhea Treatment Market Segmentation

7. Traveler's Diarrhea Treatment Market Regional And Country Analysis

8. Asia-Pacific Traveler's Diarrhea Treatment Market

9. China Traveler's Diarrhea Treatment Market

10. India Traveler's Diarrhea Treatment Market

11. Japan Traveler's Diarrhea Treatment Market

12. Australia Traveler's Diarrhea Treatment Market

13. Indonesia Traveler's Diarrhea Treatment Market

14. South Korea Traveler's Diarrhea Treatment Market

15. Western Europe Traveler's Diarrhea Treatment Market

16. UK Traveler's Diarrhea Treatment Market

17. Germany Traveler's Diarrhea Treatment Market

18. France Traveler's Diarrhea Treatment Market

19. Italy Traveler's Diarrhea Treatment Market

20. Spain Traveler's Diarrhea Treatment Market

21. Eastern Europe Traveler's Diarrhea Treatment Market

22. Russia Traveler's Diarrhea Treatment Market

23. North America Traveler's Diarrhea Treatment Market

24. USA Traveler's Diarrhea Treatment Market

25. Canada Traveler's Diarrhea Treatment Market

26. South America Traveler's Diarrhea Treatment Market

27. Brazil Traveler's Diarrhea Treatment Market

28. Middle East Traveler's Diarrhea Treatment Market

29. Africa Traveler's Diarrhea Treatment Market

30. Traveler's Diarrhea Treatment Market Competitive Landscape And Company Profiles

31. Traveler's Diarrhea Treatment Market Other Major And Innovative Companies

32. Global Traveler's Diarrhea Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Traveler's Diarrhea Treatment Market

34. Recent Developments In The Traveler's Diarrhea Treatment Market

35. Traveler's Diarrhea Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기